[1]
R. K. Portenoy, MD, “Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients”, J of Opioid Management, vol. 6, no. 5, pp. 319–328, Jan. 2018.